A University of Bonn report provides real-world outcome study on brolucizumab for neovascular AMD (nAMD)
An expert clinical research team, based at the University of Bonn, Germany, has reported a short-term real-world outcome study for intravitreal brolucizumab for neovascular AMD. … Read More »A University of Bonn report provides real-world outcome study on brolucizumab for neovascular AMD (nAMD)